摘要:
The method is performed by means of a pair of electrodes that are arranged at a distance and within a sensing zone. A nucleic acid capture molecule with an uncharged backbone and a nucleotide sequence that is at least partially complementary to at least a portion of a strand of the target nucleic acid molecule, is immobilised on an immobilisation unit. The immobilisation unit, which is arranged within the sensing zone, is contacted with a solution suspected to comprise the target nucleic acid molecule, which hybridizes to the nucleic acid capture molecule. An activation agent is added, which has an electrostatic net charge complementary to the net charge of the target nucleic acid molecule. It associates to the complex of nucleic acid capture molecule and target nucleic acid molecule. Added is a water soluble polymer with at least one polymer strand and with an electrostatic net charge that is complementary to the net charge of the activation agent. Thus the polymer associates to the activation agent. A metal salt is added, which can act as an oxidant and the metal ions of which have an electrostatic net charge complementary to the net charge of the polymer. The metal ions associate to the polymer. Upon adding a reducing agent, the latter reduces the metal ions, forming a metal wire. The presence of the analyte molecule is determined based on an electrical characteristic of a region in the sensing zone that is affected by the metal wire.
摘要:
The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
摘要:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly TrkA, TrkB, TrkC, PDGFR and c-kit.
摘要:
The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
摘要:
The present invention relates to a media processing system that comprises a bus for communicating digital signals thereon with a media processor connected to the bus, for processing signals supplied thereon. The system further has a display device connected to the bus for displaying digitized images thereon, received from the bus. The system has an audio transmitter connected to the bus, for wirelessly transmitting audio digital signals from the bus. The system further has a connectable memory for connecting to the bus and for supplying signals representing digitized images and audio digital signals to the bus. Finally the system has a receiver to receive encoded digitized images or audio digital signals for supplying the received signals to the bus for storage in the memory.
摘要:
The present invention provides a 2-amino-5-piperidinylimidazolone compound of formula I The present invention also provides methods and compositions for the inhibition of β-secretase (BACE) and the treatment of β-amyloid deposits and neurofibrillary tangles.
摘要:
The present invention relates to bicyclic derivatives, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG/S1P receptor mediated signal transduction.
摘要:
The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
摘要:
The present invention relates to a method and a device for enclosed recycling of oil-water-sludge in an oil shale dry distillation system, comprising: scrubbing and condensing oil shale dry distillation gas at a gathering pipe section, a gas tower section, an air tower section, and a cooling tower section respectively to recycle shale oil section by section; using a separator at an outlet of each section to purify and collect the shale oil, while purifying and recycling scrubbing/cooling water; using multistage dedusters to remove oil sludge entrained in an oil-water product; using an oil sludge collecting tank and a filter after the deduster to concentrate and recycle an oil sludge; and using cyclones before and after the gas tower section to remove aerosol particles and water drops entrained in circulatory gas. Advantages include: low equipment investment costs, small occupation area, low failure rate, a highly pure shale oil product and a highly concentrated oil sludge product, and recycled waste water generated in the purification and concentration processes, thereby achieving full enclosure of the device system, greatly reducing the energy consumption, and improving the oil shale dry distillation process in the prior art.
摘要:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity. wherein: A is X1 is CH or N;